Indian Market Report for Orthopedic Growth Factors - MedCore

Indian Market Report for Orthopedic Growth Factors - MedCore

  • March 2016 •
  • 29 pages •
  • Report ID: 3911733 •
  • Format: PDF
Growth factors are a group of small, soluble proteins that bind onto cell surface receptors, triggering a series of signals that regulate the body’s ability to grow, renew and heal. Due to the regenerative properties of growth factors, they have been exploited for bone healing in orthopedic applications. As of 2015 there has only been one product offered on the market in India: INFUSE® by Medtronic. There are few BMP products available in the world. Firstly, there is Stryker’s OP-1™, which had been sold to Olympus Biotech, is no longer available as Olympus Biotech ceased sales May 31, 2014. Secondly, there is Wright’s Augment®. Finally, there are less known brands from Asian manufacturers (notably Korean). INFUSE® and OP-1™ are two different forms of bone morphogenic proteins (BMPs) that belong to a larger family of proteins called transforming growth factor bs.BMPs were first discovered by Marshall Urist in 1965. Since the discovery, there have been 20 regulatory protein molecules identified to date. BMPs specifically regulate the production of bone within the human body. These proteins are functionally relevant during embryonic development in the formation of the skeleton. Urist established that demineralized bone matrix, when implanted in ectopic sites in rodents, helped to induce bone regeneration. Urist discovered that a single dose of BMP combined with autograft can repair non-union fractures that are 3 cm to 14 cm in size.BMPs are involved in many signaling pathways including those that cause increases in parathyroid hormone levels and the expression of osteocalcin, which stimulates osteoblast differentiation. These groundbreaking findings led to the isolation and cloning of several BMPs, which have been exploited for their healing properties.